No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Tisotumab Vedotin is Effective as Second- or Third-Line Therapy for Recurrent Cervical Cancer

byAstrid BradshawandAlisha Yi

July 17, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

Image-guided assessment of coronary inflammation improves cardiac risk prediction for patients without obstructive coronary artery disease

RelatedReports

StudyGraphics

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

June 19, 2025

Pharma

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

June 4, 2025

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Gastroenterology

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

April 16, 2025

Prognostic indicators for transarterial chemoembolization in patients with hepatocellular carcinoma with extrahepatic spread identified

Chronic Disease

Durvalumab and bevacizumab plus chemoembolization improves progression-free survival in hepatocellular carcinoma

March 13, 2025

Stroke expansion following intra-arterial therapy may explain worse outcomes

Reteplase associated with improved functional outcomes in ischemic stroke patients

#VisualAbstract: Temsirolimus Combined with VAC/VI Chemotherapy Did Not Improve Clinical Outcomes of Intermediate-Risk Rhabdomyosarcoma

Extensive lymphadenectomy may not increase patient survival with esophageal cancer

Benralizumab associated with histologic response in eosinophilic esophagitis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result